文献速递类风湿关节炎

医生处方模式与类风湿关节炎患者未来长期阿片类药物使用风险:前瞻性观察性队列研究

Physician Prescribing Patterns and Risk of Future Long-Term Opioid Use Among Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study.
PubMed 文献 · Arthritis Rheumatol · 2020-01-01

该研究基于Corrona类风湿关节炎(RA)注册中心,分析医生基线阿片类药物处方率与患者未来长期阿片使用的关系。结果显示,中、高处方率医生所治患者长期阿片使用的OR分别为1.89和2.01,提示基线处方率是未来长期使用的强预测因素。

要点

  • 医生基线阿片处方率与患者未来长期阿片使用风险显著相关。
  • 中、高处方率医生所治患者的长期使用OR分别为1.89和2.01。
  • 低处方率医生所治患者长期使用风险与极低处方率者无显著差异。

核心结论

  • 在控制患者特征后,医生基线阿片处方率是RA患者未来长期阿片使用的强预测因素。

研究设计与样本

  • 前瞻性观察性队列研究,纳入Corrona RA注册中心中参与前12个月贡献≥10例患者的医生及其RA患者。

主要发现

  • 极低处方率医生所治患者长期阿片使用率为7.0%(163/2322)。
  • 低处方率医生所治患者长期使用率为6.8%(153/2254),OR为1.16(95%CI 0.79-1.70)。
  • 中处方率医生所治患者长期使用率为12.5%(294/2352),OR为1.89(95%CI 1.27-2.82)。
  • 高处方率医生所治患者长期使用率为12.7%(307/2409),OR为2.01(95%CI 1.43-2.83)。

临床怎么用

  • 临床中应关注医生阿片处方模式对RA患者长期阿片使用风险的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the extent to which opioid prescribing rates for patients with rheumatoid arthritis (RA) vary in the US and to determine the implications of baseline opioid prescribing rates on the probability of future long-term opioid use. METHODS: We identified patients with RA from physicians who contributed ≥10 patients within the first 12 months of participation in the Corrona RA Registry. The baseline opioid prescribing rate was calculated by dividing the number of patients with RA reporting opioid use during the first 12 months by the number of patients with RA providing data that year. To estimate odds ratios (ORs) for long-term opioid use, we used generalized linear mixed models. RESULTS: During the follow-up period, long-term opioid use was reported by 7.0% (163 of 2,322) of patients of physicians with a very low rate of opioid prescribing (referent) compared to 6.8% (153 of 2,254) of patients of physicians with a low prescribing rate, 12.5% (294 of 2,352) of patients of physicians with a moderate prescribing rate, and 12.7% (307 of 2,409) of patients of physicians with a high prescribing rate. The OR for long-term opioid use after the baseline period was 1.16 (95% confidence interval [95% CI] 0.79-1.70) for patients of low-intensity prescribing physicians, 1.89 (95% CI 1.27-2.82) for patients of moderate-intensity prescribing physicians, and 2.01 (95% CI 1.43-2.83) for patients of high-intensity prescribing physicians, compared to very low-intensity prescribing physicians. CONCLUSION: Rates of opioid prescriptions vary widely. Our findings indicate that baseline opioid prescribing rates are a strong predictor of whether a patient will become a long-term opioid user in the future, after controlling for patient characteristics.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Lee YC, Lu B, Guan H, et al. Physician Prescribing Patterns and Risk of Future Long-Term Opioid Use Among Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study. Arthritis Rheumatol. 2020. PMID: 32103630. doi:10.1002/art.41240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。